Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Profit After Tax: 2009-2025

Historic Profit After Tax for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Profit After Tax fell 205.35% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 346.28%. This contributed to the annual value of -$480,000 for FY2024, which is 94.31% up from last year.
  • Per Rockwell Medical's latest filing, its Profit After Tax stood at -$1.8 million for Q3 2025, which was down 17.49% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Profit After Tax registered a high of $1.7 million during Q3 2024, and its lowest value of -$8.9 million during Q4 2021.
  • Moreover, its 3-year median value for Profit After Tax was -$1.5 million (2025), whereas its average is -$1.2 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 188.89% in 2024, then tumbled by 534.99% in 2025.
  • MRQ analysis of 5 years shows Rockwell Medical's Profit After Tax stood at -$8.9 million in 2021, then skyrocketed by 73.58% to -$2.4 million in 2022, then soared by 35.99% to -$1.5 million in 2023, then surged by 50.00% to -$756,000 in 2024, then tumbled by 131.88% to -$1.8 million in 2025.
  • Its last three reported values are -$1.8 million in Q3 2025, -$1.5 million for Q2 2025, and -$1.5 million during Q1 2025.